Cargando…

In Vivo Pharmacodynamics of Calophyllum soulattri as Antiobesity with In Silico Molecular Docking and ADME/Pharmacokinetic Prediction Studies

This study aims to determine the antiobesity activity of Calophyllum soulattri leaves extract (CSLE) on high fat diet-fed rats (HFD) and to predict the molecular docking and pharmacokinetics of selected compounds of Calophyllum soulattri to fat mass and obesity-associated protein (FTO). Daily body w...

Descripción completa

Detalles Bibliográficos
Autores principales: Fajriaty, Inarah, Ih, Hariyanto, Fidrianny, Irda, Kurniati, Neng Fisheri, Reynaldi, Muhammad Andre, Adnyana, I Ketut, Rommy, Rommy, Kurniawan, Fransiska, Tjahjono, Daryono Hadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962277/
https://www.ncbi.nlm.nih.gov/pubmed/37259340
http://dx.doi.org/10.3390/ph16020191
_version_ 1784895964412116992
author Fajriaty, Inarah
Ih, Hariyanto
Fidrianny, Irda
Kurniati, Neng Fisheri
Reynaldi, Muhammad Andre
Adnyana, I Ketut
Rommy, Rommy
Kurniawan, Fransiska
Tjahjono, Daryono Hadi
author_facet Fajriaty, Inarah
Ih, Hariyanto
Fidrianny, Irda
Kurniati, Neng Fisheri
Reynaldi, Muhammad Andre
Adnyana, I Ketut
Rommy, Rommy
Kurniawan, Fransiska
Tjahjono, Daryono Hadi
author_sort Fajriaty, Inarah
collection PubMed
description This study aims to determine the antiobesity activity of Calophyllum soulattri leaves extract (CSLE) on high fat diet-fed rats (HFD) and to predict the molecular docking and pharmacokinetics of selected compounds of Calophyllum soulattri to fat mass and obesity-associated protein (FTO). Daily body weight, organ, carcass fat (renal and anal), body mass index, total cholesterol, and total triglyceride levels were observed after CSLE was given orally for 50 days. Furthermore, body mass index of a CSLE dose of 50 mg/kgbw, 100 mg/kgbw and orlistat (120 mg/kgbw) group are 0.68, 0.57 and 0.52, respectively. The total body weight of the CLSE dose of 100 mg/kgbw group showed the lowest percentage change, followed by a CLSE dose of 50 mg/kgbw compared to the normal and positive control group. The carcass fat index of CSLE dose of 100 mg/kgbw was not significantly different from orlistat, which was in line with its total cholesterol level and triglyceride (p < 0.05). The binding affinity of selected compounds from Calophyllum soulattri (friedelin, caloxanthone B, macluraxanthone, stigmasterol, trapezifolixanthone, dombakinaxanthone, and brasixanthone B) to FTO are –8.27, –9.74, –8.48, –9.34, –8.85, –8.68 and –9.39 kcal/mol, which are better than that of orlistat at –4.80 kcal/mol. The molecular dynamics simulation showed that the interaction between Caloxanthone B compounds and obesity receptors was relatively stable. Lipinski’s rule determined the absorption percentage of all compounds above 90% with good drug-likeness. The results showed the potential of CSLE as an antiobesity drug candidate.
format Online
Article
Text
id pubmed-9962277
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99622772023-02-26 In Vivo Pharmacodynamics of Calophyllum soulattri as Antiobesity with In Silico Molecular Docking and ADME/Pharmacokinetic Prediction Studies Fajriaty, Inarah Ih, Hariyanto Fidrianny, Irda Kurniati, Neng Fisheri Reynaldi, Muhammad Andre Adnyana, I Ketut Rommy, Rommy Kurniawan, Fransiska Tjahjono, Daryono Hadi Pharmaceuticals (Basel) Article This study aims to determine the antiobesity activity of Calophyllum soulattri leaves extract (CSLE) on high fat diet-fed rats (HFD) and to predict the molecular docking and pharmacokinetics of selected compounds of Calophyllum soulattri to fat mass and obesity-associated protein (FTO). Daily body weight, organ, carcass fat (renal and anal), body mass index, total cholesterol, and total triglyceride levels were observed after CSLE was given orally for 50 days. Furthermore, body mass index of a CSLE dose of 50 mg/kgbw, 100 mg/kgbw and orlistat (120 mg/kgbw) group are 0.68, 0.57 and 0.52, respectively. The total body weight of the CLSE dose of 100 mg/kgbw group showed the lowest percentage change, followed by a CLSE dose of 50 mg/kgbw compared to the normal and positive control group. The carcass fat index of CSLE dose of 100 mg/kgbw was not significantly different from orlistat, which was in line with its total cholesterol level and triglyceride (p < 0.05). The binding affinity of selected compounds from Calophyllum soulattri (friedelin, caloxanthone B, macluraxanthone, stigmasterol, trapezifolixanthone, dombakinaxanthone, and brasixanthone B) to FTO are –8.27, –9.74, –8.48, –9.34, –8.85, –8.68 and –9.39 kcal/mol, which are better than that of orlistat at –4.80 kcal/mol. The molecular dynamics simulation showed that the interaction between Caloxanthone B compounds and obesity receptors was relatively stable. Lipinski’s rule determined the absorption percentage of all compounds above 90% with good drug-likeness. The results showed the potential of CSLE as an antiobesity drug candidate. MDPI 2023-01-28 /pmc/articles/PMC9962277/ /pubmed/37259340 http://dx.doi.org/10.3390/ph16020191 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fajriaty, Inarah
Ih, Hariyanto
Fidrianny, Irda
Kurniati, Neng Fisheri
Reynaldi, Muhammad Andre
Adnyana, I Ketut
Rommy, Rommy
Kurniawan, Fransiska
Tjahjono, Daryono Hadi
In Vivo Pharmacodynamics of Calophyllum soulattri as Antiobesity with In Silico Molecular Docking and ADME/Pharmacokinetic Prediction Studies
title In Vivo Pharmacodynamics of Calophyllum soulattri as Antiobesity with In Silico Molecular Docking and ADME/Pharmacokinetic Prediction Studies
title_full In Vivo Pharmacodynamics of Calophyllum soulattri as Antiobesity with In Silico Molecular Docking and ADME/Pharmacokinetic Prediction Studies
title_fullStr In Vivo Pharmacodynamics of Calophyllum soulattri as Antiobesity with In Silico Molecular Docking and ADME/Pharmacokinetic Prediction Studies
title_full_unstemmed In Vivo Pharmacodynamics of Calophyllum soulattri as Antiobesity with In Silico Molecular Docking and ADME/Pharmacokinetic Prediction Studies
title_short In Vivo Pharmacodynamics of Calophyllum soulattri as Antiobesity with In Silico Molecular Docking and ADME/Pharmacokinetic Prediction Studies
title_sort in vivo pharmacodynamics of calophyllum soulattri as antiobesity with in silico molecular docking and adme/pharmacokinetic prediction studies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962277/
https://www.ncbi.nlm.nih.gov/pubmed/37259340
http://dx.doi.org/10.3390/ph16020191
work_keys_str_mv AT fajriatyinarah invivopharmacodynamicsofcalophyllumsoulattriasantiobesitywithinsilicomoleculardockingandadmepharmacokineticpredictionstudies
AT ihhariyanto invivopharmacodynamicsofcalophyllumsoulattriasantiobesitywithinsilicomoleculardockingandadmepharmacokineticpredictionstudies
AT fidriannyirda invivopharmacodynamicsofcalophyllumsoulattriasantiobesitywithinsilicomoleculardockingandadmepharmacokineticpredictionstudies
AT kurniatinengfisheri invivopharmacodynamicsofcalophyllumsoulattriasantiobesitywithinsilicomoleculardockingandadmepharmacokineticpredictionstudies
AT reynaldimuhammadandre invivopharmacodynamicsofcalophyllumsoulattriasantiobesitywithinsilicomoleculardockingandadmepharmacokineticpredictionstudies
AT adnyanaiketut invivopharmacodynamicsofcalophyllumsoulattriasantiobesitywithinsilicomoleculardockingandadmepharmacokineticpredictionstudies
AT rommyrommy invivopharmacodynamicsofcalophyllumsoulattriasantiobesitywithinsilicomoleculardockingandadmepharmacokineticpredictionstudies
AT kurniawanfransiska invivopharmacodynamicsofcalophyllumsoulattriasantiobesitywithinsilicomoleculardockingandadmepharmacokineticpredictionstudies
AT tjahjonodaryonohadi invivopharmacodynamicsofcalophyllumsoulattriasantiobesitywithinsilicomoleculardockingandadmepharmacokineticpredictionstudies